DIASPOT Platform Expansion
Autoimmune Diseases
Commercial & DevelopmentActive
Key Facts
About DIAsource ImmunoAssays
DiaSource Diagnostics is a long-established, specialized player in the global IVD market, leveraging deep expertise in immunoassay technologies like RIA and ELISA. The company has expanded its portfolio from traditional manual kits to include innovative automated platforms, most notably its DIASPOT technology and Neptune instrument for autoimmune disease testing. Its recent integration into the BioVendor Group provides a stronger commercial and structural foundation for global growth. DiaSource operates as a revenue-generating, private entity, serving clinical laboratories worldwide with a focus on reliable, specialized diagnostic solutions.
View full company profileTherapeutic Areas
Other Autoimmune Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Humira (Adalimumab) Biosimilar | NeuClone | Early Preclinical |
| HBM7020 | Harbour BioMed | Discovery |
| R2006 | Harbour BioMed | Discovery |
| R7027 | Harbour BioMed | Discovery |
| ImmCelz™ Platform | Creative Medical Technology Holdings | Preclinical |
| Not specified in provided content | 3Sbio | Various |
| Gavocabtagene autoleucel | astellas | Phase 1/2 |
| TYK-101 | TYK Medicines | Phase 1 |
| HCB206 | HanchorBio | Preclinical |
| miR-124 Activator | Formation Bio | Phase 2 |
| Autologous Cell Therapy Collaboration | Lupagen | Preclinical |
| Autoimmune Diagnostics Leadership Initiative | Vibrant America Clinical Laboratory | Commercial |